Quick10K

⚲

Filings

10-Q	2021-03-31	Filed 2021-05-07
10-K	2020-12-31	Filed 2021-03-15
10-Q	2020-09-30	Filed 2020-11-06
10-Q	2020-06-30	Filed 2020-08-07
10-Q	2020-03-31	Filed 2020-05-11
10-K	2019-12-31	Filed 2020-03-16
10-Q	2019-09-30	Filed 2019-11-08
10-Q	2019-06-30	Filed 2019-08-09
10-Q	2019-03-31	Filed 2019-05-10
10-K	2018-12-31	Filed 2019-03-18
10-Q	2018-09-30	Filed 2018-11-08
10-Q	2018-06-30	Filed 2018-08-09
10-Q	2018-03-31	Filed 2018-05-10
10-K	2017-12-31	Filed 2018-04-02
10-Q	2017-09-30	Filed 2017-11-09
10-Q	2017-06-30	Filed 2017-08-14
10-Q	2017-03-31	Filed 2017-05-04
10-K	2016-12-31	Filed 2017-03-16
10-Q	2016-09-30	Filed 2016-11-04
10-Q	2016-06-30	Filed 2016-08-04
10-Q	2016-03-31	Filed 2016-05-05
10-K	2015-12-31	Filed 2016-03-15
10-Q	2015-09-30	Filed 2015-11-05
10-Q	2015-06-30	Filed 2015-08-06
10-Q	2015-03-31	Filed 2015-05-07
10-K	2014-12-31	Filed 2015-03-16
10-Q	2014-09-30	Filed 2014-11-10
10-Q	2014-06-30	Filed 2014-08-08
10-Q	2014-03-31	Filed 2014-05-09
10-K	2013-12-31	Filed 2014-03-14
10-Q	2013-09-30	Filed 2013-11-08
10-Q	2013-06-30	Filed 2013-08-08
10-Q	2013-03-31	Filed 2013-05-10
10-K	2012-12-31	Filed 2013-03-15
10-Q	2012-09-30	Filed 2012-11-08
10-Q	2012-06-30	Filed 2012-08-08
10-Q	2012-03-31	Filed 2012-05-08
10-K	2011-12-31	Filed 2012-03-15
10-Q	2011-09-30	Filed 2011-11-08
10-Q	2011-06-30	Filed 2011-08-09
10-Q	2011-03-31	Filed 2011-05-10
10-K	2010-12-31	Filed 2011-03-15
10-Q	2010-09-30	Filed 2010-11-09
10-Q	2010-06-30	Filed 2010-08-11
10-Q	2010-03-31	Filed 2010-05-10
10-K	2009-12-31	Filed 2010-03-31

Reports

8-K	2020-11-05
8-K	2020-10-19
8-K	2020-10-06
8-K	2020-08-22
8-K	2020-08-06
8-K	2020-07-29
8-K	2020-05-29
8-K	2020-05-20
8-K	2020-05-07
8-K	2020-04-15
8-K	2020-04-06
8-K	2020-03-12
8-K	2020-02-17
8-K	2020-01-31
8-K	2019-12-27
8-K	2019-12-19
8-K	2019-12-11
8-K	2019-12-05
8-K	2019-11-24
8-K	2019-11-07
8-K	2019-10-29
8-K	2019-10-21
8-K	2019-09-23
8-K	2019-09-20
8-K	2019-09-15
8-K	2019-08-23
8-K	2019-08-08
8-K	2019-07-12
8-K	2019-06-11
8-K	2019-05-16
8-K	2019-05-09
8-K	2019-03-15
8-K	2019-03-13
8-K	2019-03-13
8-K	2019-02-25
8-K	2019-02-01
8-K	2018-12-26
8-K	2018-11-07
8-K	2018-09-18
8-K	2018-09-13
8-K	2018-08-09
8-K	2018-08-08
8-K	2018-05-18
8-K	2018-05-09
8-K	2018-05-07
8-K	2018-04-02
8-K	2018-04-02
8-K	2018-03-08
8-K	2018-01-02

NN Financials

NNBR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	10	12	5	12	12	14	19	8	5	4	3	5	6	27	37	17	21	40	15	15	15	15	14	20	19	347	224	185	23	18	18	20	22	24
Accounts Receivable	82	73	67	76	71	64	52	67	68	66	59	74	81	113	98	117	115	108	123	143	147	147	140	160	162	108	108	120	147	150	133	147	151	142
Inventory	43	44	46	46	45	46	46	45	47	48	55	57	62	87	91	86	88	93	120	120	119	119	115	117	124	77	83	92	116	124	123	129	129	127
PP&E	124	120	121	122	119	119	319	117	115	117	339	126	133	275	498	265	272	267	546	325	323	326	582	328	333	239	372	267	334	352	506	353	368	364
Assets	279	269	259	274	265	261	265	265	261	261	262	287	307	713	713	694	709	719	1,394	1,396	1,390	1,382	1,360	1,391	1,406	1,518	1,475	1,485	1,761	1,763	1,502	1,581	1,572	1,554
Accounts Payable	55	46	48	43	40	36	37	39	40	43	41	46	49	63	71	62	64	60	69	70	66	70	76	78	78	48	53	55	55	66	66	74	64	66
Long-Term Debt	87	90	78	87	82	75	70	64	52	39	36	50	58	355	350	358	359	206	820	817	821	804	825	810	852	837	829	826	1,092	893	860	873	888	879
Liabilities	178	170	160	165	154	144	137	135	125	117	110	130	144	533	539	533	535	376	1,080	1,078	1,072	1,055	1,045	1,063	1,094	1,076	989	1,000	1,318	1,122	1,083	1,186	1,194	1,194
Stockholders' Equity	100	99	100	109	110	117	129	130	136	145	153	157	164	180	174	161	174	344	314	317


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	116	101	96	105	102	87	80	94	104	93	90	103	116	126	154	164	165	155	184	212	214	205	202	226	226	148	156	169	196	206	199	213	222	214
Cost of Revenue
Gross Profit
R&D
SG&A	8	7	7	8	9	8	7	9	10	8	8	10	12	11	14	12	14	12	14	21	22	18	20	21	26	17	22	22	27	22		28	27	24
Tax	2	1	0	1	1	1	-8	1	3	2	2	2	2	-1	2	1	2	1	-15	-1	1	-6	-3	2	-1	-1	-65	-1	-6	-6		2	1	-1
Net Income	6	5	5	6	8	3	8	3	5	5	4	5	5	-4	2	6	7	5	-25	-1	2	4	3	7	-22	133	44	-6	-25	-14	-220	-19	-7	-6


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		5	12	-1	13	11	15	-2	11	17	6	-1	7	-4	29	-17	22	9	20	3	8	35	23	5	-21	16	-60	-1		6		-3	7	29
Cash Investing		-5	-5	-2	-5	-3	-5	-3	-2	-4	-6	-9	-13	-250	-10	-9	-17	-8	-632	-8	-8	-14	-11	-9	-12	353	-50	-33		-24		-4	-16	-11
Cash Financing		4	-12	9	-6	-7	-6	-6	-12	-13	-1	12	7	275	-7	6	-0	17	588	5	2	-22	-9	8	31	-41	-13	-6		12		9	11	-13